RE-BVS – Piemonte Repository

Sfoglia per AUTORE
SARTOR C
Collezione AOU Città della Salute di Torino

Items : 7

Impact of inotuzumab ozogamicin on outcome in relapsed or refractory acute B-cell lymphoblastic leukemia patients prior to allogeneic hematopoietic stem cell transplantation and risk of sinusoidal obstruction syndrome/venous occlusive disease. in Haematologica / Haematologica. 2024 May 1;109(5):1385-1392. doi: 10.3324/haematol.2023.284310.

2024
AOU Città della Salute di Torino

Kayser S; Sartor C; Giglio F; Bruno A; Webster J; Chiusolo P; Saraceni F; Guerzoni S; Pochintesta L; Borlenghi E; Marconi G; Zacheo I; Cerrano M; Salutari P; Restuccia F; Abbenante M; Levis MJ; Schlenk RF; Papayannidis C;

Management of latent tuberculosis infection (LTBI) in adult patients with newly diagnosed acute leukemia: results of a survey among Italian centers belonging to SEIFEM (Sorveglianza Epidemiologica Infezioni nelle Emopatie) group. in Annals of hematology / Ann Hematol. 2024 Dec;103(12):6045-6050. doi: 10.1007/s00277-024-06047-6. Epub 2024 Oct 28.

2024
AOU Città della Salute di Torino

Forghieri F; Bettelli F; Sgromo S; Nadali G; Del Principe MI; Buzzatti E; Farina F; Cesini L; Giordano A; Criscuolo M; Facchinelli D; Piedimonte M; Sartor C; De Marchi R; Delia M; Mosna F; Cudillo L; Tolomelli G; Basilico CM; Cattaneo C; Fracchiolla NS; Lessi F; Finizio O; Zannetti BA; Santoni A; Fazi P; Marchesi F; Venditti A; Candoni A; et alii...

Blinatumomab and Inotuzumab Ozogamicin Sequential Use for the Treatment of Relapsed/Refractory Acute Lymphoblastic Leukemia: A Real-Life Campus All Study. in Cancers / Cancers (Basel). 2023 Sep 19;15(18):4623. doi: 10.3390/cancers15184623.

2023
AOU Città della Salute di Torino
AOU Novara

Foà R; Curti A; Passamonti F; Sartor C; Buzzatti E; Barozzi E; De Roberto P; Canzi M; Santoro L; Tagliaferri E; Zappasodi P; Cerrano M; Del Principe MI; Defina M; Todisco E; Gurrieri C; Dargenio M; Bonifacio M; Scappini B; Imovilli A; Lunghi M; Lazzarotto D; Forghieri F; Salutari P; Annunziata M; Giglio F; Chiaretti S; Vitale A; Papayannidis C; et alii...

A venetoclax and azacitidine bridge-to-transplant strategy for NPM1-mutated acute myeloid leukaemia in molecular failure. in British journal of haematology / Br J Haematol. 2023 Aug;202(3):599-607. doi: 10.1111/bjh.18887. Epub 2023 May 24.

2023
AO Ordine Mauriziano
AOU Città della Salute di Torino

Martelli MP; Curti A; Papayannidis C; Cavo M; Cardinali V; Sciabolacci S; Forte D; Bandini L; Ottaviani E; Patuelli A; Zingarelli F; Ciruolo R; Nanni J; Cristiano G; Zannoni L; Cignetti A; Audisio E; Brunetti L; Sartor C;

An IDO1-related immune gene signature predicts overall survival in acute myeloid leukemia. in Blood advances / Blood Adv. 2022 Jan 11;6(1):87-99. doi: 10.1182/bloodadvances.2021004878.

2022
AOU Città della Salute di Torino

Ragaini S; Wagner S; Marconi G; Parisi S; Sartor C; Nanni J; Cristiano G; Talami A; Olivi M; Ocadlikova D; Ciciarello M; Corradi G; Ottaviani E; Papayannidis C; Paolini S; Vadakekolathu J; Cavo M; Rutella S; Curti A;

Safety profile and impact on survival of tyrosine kinase inhibitors versus conventional therapy in relapse or refractory FLT3 positive acute myeloid leukemia patients. in Leukemia research / Leuk Res. 2021 Feb;101:106497. doi: 10.1016/j.leukres.2020.106497. Epub 2020 Dec 25.

2021
AOU Città della Salute di Torino

Paolini S; Curti A; Bonifazi F; Testoni N; Baldazzi C; Cristiano G; Raffini M; Fontana MC; Parisi S; Ottaviani E; Bochicchio MT; Sartor C; Abbenante MC; Ragaini S; Olivi M; Talami A; Bertamini L; Nanni J; Martinelli G; De Polo S; Marconi G; Cavo M; Papayannidis C;

MEC (mitoxantrone, etoposide, and cytarabine) induces complete remission and is an effective bridge to transplant in acute myeloid leukemia. in European journal of haematology / Eur J Haematol. 2020 Jul;105(1):47-55. doi: 10.1111/ejh.13406. Epub 2020 Apr 7.

2020
AOU Città della Salute di Torino

Marconi G; Talami A; Abbenante MC; Sartor C; Parisi S; Nanni J; Bertamini L; Ragaini S; Olivi M; de Polo S; Cristiano G; Fontana MC; Bochicchio MT; Ottaviani E; Arpinati M; Sessa M; Baldazzi C; Caso L; Testoni N; Baccarani M; Bonifazi F; Martinelli G; Paolini S; Cavo M; Papayannidis C; Curti A;